Overview
Hidrotic ectodermal dysplasia, also known as Clouston syndrome, is a rare genetic disorder belonging to the group of ectodermal dysplasias — conditions that affect structures derived from the embryonic ectoderm. It is caused by mutations in the GJB6 gene, which encodes connexin 30, a gap junction protein important for cell-to-cell communication in the skin and its appendages. Unlike other forms of ectodermal dysplasia, hidrotic ectodermal dysplasia notably preserves sweat gland function (hence the term 'hidrotic,' meaning sweating is intact), while primarily affecting the hair, nails, and skin. The hallmark clinical features include severe nail dystrophy (thickened, slow-growing, discolored, or absent nails), sparse to absent scalp hair (hypotrichosis or alopecia that may be progressive), and sparse or absent body hair including eyebrows and eyelashes. The nails are often the most consistently affected feature and may be present from birth or early childhood. Palmoplantar hyperkeratosis — thickening of the skin on the palms and soles — is another common finding. Teeth and sweat glands are typically normal, which distinguishes this condition from hypohidrotic forms of ectodermal dysplasia. Some affected individuals may also develop hyperpigmentation of the skin, particularly over the joints. There is currently no cure for hidrotic ectodermal dysplasia. Treatment is symptomatic and supportive, focusing on management of nail abnormalities, skin care for hyperkeratotic areas, and cosmetic solutions such as wigs for hair loss. Dermatologic follow-up is recommended. Genetic counseling is important for affected families given the autosomal dominant inheritance pattern. The condition was originally described in a large French-Canadian kindred, and notable clusters have been reported in this population, though cases occur worldwide across various ethnic groups.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Hidrotic ectodermal dysplasia.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Hidrotic ectodermal dysplasia at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Hidrotic ectodermal dysplasia.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Hidrotic ectodermal dysplasia.
Community
No community posts yet. Be the first to share your experience with Hidrotic ectodermal dysplasia.
Start the conversation →Latest news about Hidrotic ectodermal dysplasia
No recent news articles for Hidrotic ectodermal dysplasia.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Hidrotic ectodermal dysplasia
What is Hidrotic ectodermal dysplasia?
Hidrotic ectodermal dysplasia, also known as Clouston syndrome, is a rare genetic disorder belonging to the group of ectodermal dysplasias — conditions that affect structures derived from the embryonic ectoderm. It is caused by mutations in the GJB6 gene, which encodes connexin 30, a gap junction protein important for cell-to-cell communication in the skin and its appendages. Unlike other forms of ectodermal dysplasia, hidrotic ectodermal dysplasia notably preserves sweat gland function (hence the term 'hidrotic,' meaning sweating is intact), while primarily affecting the hair, nails, and skin
How is Hidrotic ectodermal dysplasia inherited?
Hidrotic ectodermal dysplasia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Hidrotic ectodermal dysplasia typically begin?
Typical onset of Hidrotic ectodermal dysplasia is childhood. Age of onset can vary across affected individuals.